Antibody-Drug Conjugates Used in Breast Cancers
- PMID: 34257655
- PMCID: PMC8257388
- DOI: 10.1155/2021/9927433
Antibody-Drug Conjugates Used in Breast Cancers
Abstract
The prognosis of breast cancer has radically changed in recent years and continues to improve due to the broad application of effective therapies. New targeting strategies including targeted delivery of cytotoxic drugs via receptor-targeting agents have been developed. We summarize recent publications and developments of novel antibody-drug conjugates (ADCs) used to control breast cancer.
Copyright © 2021 Aram J. Abbas et al.
Conflict of interest statement
The authors declare that there are no conflicts of interest regarding the publication of this paper.
Figures
References
-
- World Health Organization. Cancer. Berlin, Germany: World Health Organization; 2018. https://www.who.int/news-room/fact-sheets/detail/cancer.
Publication types
LinkOut - more resources
Full Text Sources
